Skip to main content
Find Eczema-Friendly ProductsFind a Doctor
Logo
search
menu
About Eczema
Research
News & Stories
Get Involved
About Us
Donate
generic image

Press Releases

Optional secondary text goes here up to 160 characters. Lorem ipsum dolor sit amet consectetur. Pretium volutpat nec turpis cursus id malesuada at urna.

  1. Home
  2. Press release
Toggle drawer

Get the latest in eczema news, delivered.

Sign up for NEA's e-newsletter to receive evidence-based articles, expert-sourced lifestyle tips and stories from your community.

Nea footer logo
  • About NEA
  • Press Room
  • Contact Us
  • Careers
  • Seal of Acceptance Application
  • Partnership Opportunities
  • Privacy Policy
  • Terms and Conditions
facebookXyoutubesocial iconthreadslinked-in

The National Eczema Association (NEA) improves the health and quality of life for people affected by eczema, and empowers those who advocate, support and deliver care.

Our Accreditations

National Health Council standards of excellence certification programGuide Star Seal of TransparencyBetter Business Bureau accredited charityGlobal Skin internation alliance of dermatology patient organizationsaccreditation logo

NEA is a qualified 501(c)(3) EIN 93-0988840.

© National Eczema Association, All rights reserved 2026

Filter Title
Filter Title (1)
Currently showing 1 - 10 of 31 results
Sort By
Select an option

Eczema Re-listed as Eligible Condition for Department of Defense’s Peer-reviewed Medical Research Program for Fiscal Year 2025

November 05, 2025
Read More

New Research Finds Adults, Children and Teens with Eczema Experience Significant Mental Health Symptoms

March 27, 2025
Read More

New Research Finds Nearly 1 in 5 Adult Eczema Patients Have Multiple Eczema Conditions

March 17, 2025
Read More

Lorem ipsum dolor sit amet consectetur. Est tempor ultrices scelerisque

March 05, 2025
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard...
Read More

NEA Announces New Tower 28 Scholarship Fund to Support Patients and Caregivers Attending Eczema Expo

February 28, 2025
Read More

NEA Awards 9 New Grants for Eczema Research to New and Longstanding Investigators

February 27, 2025
Read More

Galderma Receives U.S. FDA Approval for Nemluvio® (Nemolizumab) for Patients with Moderate-to-Severe Atopic Dermatitis

December 13, 2024
Zug, Switzerland – December 13, 2024 – Galderma today announced that the United States (U.S.) Food and Drug Administration...
Read More

 Astria Therapeutics Announces FDA Clearance of IND Application for STAR-0310, a Monoclonal Antibody OX40 Antagonist for the Treatment of Atopic Dermatitis 

December 10, 2024
— Phase 1a Trial of STAR-0310 in Healthy Volunteers Expected to Initiate in Q1 2025 — — Early Proof-of-Concept...
Read More

FDA Accepts LEO Pharma’s Filing of Delgocitinib Cream New Drug Application for the Treatment of Chronic Hand Eczema

September 24, 2024
September 23, 2024 06:00 AM Eastern Daylight Time MADISON, New Jersey–(BUSINESS WIRE)–NOT FOR UK USE – NOT INTENDED FOR...
Read More

FDA Approves Lilly’s EBGLYSS™ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis

September 16, 2024
INDIANAPOLIS, Sept. 13, 2024 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug...
Read More
Previous
  • 1
  • 2
  • 3
  • 4
Next